Improved outcome in patients with acute myelogenous leukaemia post high-dose chemotherapy with the combination of BCNU, cytarabine, melphalan and autologous haematopoietic cell transplantation

被引：0
|
作者：
Sakellari, I. [1 ]
Mallouri, D. [1 ]
Apostolou, C. [1 ]
Antoniou, A. [1 ]
Batsis, I. [1 ]
Kaloyannidis, P. [1 ]
Kelaidi, C. [1 ]
Tsimperis, S. [1 ]
Smias, C. [1 ]
Papaioannou, G. [1 ]
Sotiropoulos, D. [1 ]
Dourvas, G. [1 ]
Saloum, R. [1 ]
Anagnostopoulos, A. [1 ]
Fassas, A. [1 ]
机构：
[1] G Papanicolaou Hosp, Thessaloniki, Greece
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
下载
收藏
页码：S275 / S275
页数：1
相关论文
共 50 条
  • [11] Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia
    Tsimberidou, AM
    Stavroyianni, N
    Viniou, N
    Papaioannou, M
    Tiniakou, M
    Marinakis, T
    Skandali, A
    Sakellari, L
    Yataganas, X
    CANCER, 2003, 97 (07) : 1721 - 1731
  • [12] The unfavourable clinical outcome of mantle cell lymphoma is not improved by high-dose chemotherapy and autologous stem cell transplantation
    Van de Velde, AL
    Gadisseur, AP
    Steel, E
    Van Steenweghen, S
    Schroyens, W
    Berneman, ZN
    Zachee, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S350 - S350
  • [13] High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation
    Gesine Bug
    Johannes Atta
    Stefan A. Klein
    Bernd Hertenstein
    Lothar Bergmann
    Simone Boehrer
    Sabine Mousset
    Dieter Hoelzer
    Hans Martin
    Annals of Hematology, 2005, 84 : 748 - 754
  • [14] Acute promyelocytic leukaemia after high-dose chemotherapy and autologous stem cell transplantation in a patient with multiple sclerosis
    Lisukov, I
    Kulagin, A
    Sizikova, S
    Kruchkova, I
    Malysheva, O
    Denisova, V
    Gilevich, A
    Kozlov, V
    BONE MARROW TRANSPLANTATION, 2005, 35 : S379 - S379
  • [15] High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation
    Bug, G
    Atta, J
    Klein, SA
    Hertenstein, B
    Bergmann, L
    Boehrer, S
    Mousset, S
    Hoelzer, D
    Martin, H
    ANNALS OF HEMATOLOGY, 2005, 84 (11) : 748 - 754
  • [16] The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma
    Cakar, Merih K.
    Tekgunduz, Emre
    Dal, Mehmet S.
    Merdin, Alparslan
    Basci, Semih
    Iskender, Dicle
    Ugur, Bilge
    Bekdemir, Filiz
    Yildiz, Jale
    Ulu, Bahar U.
    Bakirtas, Mehmet
    Yigenoglu, Tugce N.
    Batgi, Hikmetullah
    Kaya, Ali H.
    Altuntas, Fevzi
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 273 - 278
  • [17] High-dose chemotherapy with treosulfan and melphalan before autologous transplantation in multiple myeloma
    Gillich, C.
    Jeker, B.
    Aebi, Y.
    Largiader, C.
    Hayoz, M.
    Taleghani, B. Mansouri
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 21 - 21
  • [18] High-dose melphalan with BCNU and etoposide as preparative regimen for autologous hemopoietic stem cell transplantation in multiple myeloma (MM)
    Bernasconi, P
    Alessandrino, EP
    Colombo, AA
    Caldera, D
    Bonfichi, M
    Martinelli, G
    Malcovati, L
    Varettoni, M
    Maiocchi, M
    Brusamolino, E
    Pagnucco, G
    Castagnola, C
    Corso, A
    Bernasconi, C
    BONE MARROW TRANSPLANTATION, 1999, 23 : S133 - S133
  • [19] High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma
    Solomon, Scott R.
    Brown, Stacey
    Shegda, Nancy
    Jackson, Katelin C.
    Zhang, Xu
    Bashey, Asad
    Holland, H. Kent
    Morris, Lawrence E.
    Solh, Melhem
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (08): : 486.e1 - 486.e7
  • [20] TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) is an effective high-dose chemotherapy consolidation regimen with autologous stem cell transplantation for patients with relapsed lymphoma in complete remission
    Pester, F.
    Klink, A.
    Scholl, S.
    Schilling, K.
    Muegge, L.
    Hoeffken, K.
    Sayer, H.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S252 - S252
12345